Noroclav Injection for Dogs and Cats
Noroclav injection contains a sterile off-white suspension containing 140mg/mL amoxycillin and 35mg/mL clavulanic acid. It is indicated for the treatment of bacteria sensitive to amoxycillin. Clavulanate extends the antibacterial spectrum of amoxycillin by making it active against resistant beta-lactamase producing bacteria.
Target Species: Dogs and cats
-
Active Ingredient
140mg/mL amoxycillin and 35mg/mL clavulanic acid
-
Pharmaceutical Form
Suspension for injection
-
Indications
It has a broad spectrum of bactericidal activity against bacteria sensitive to amoxycillin. Clavulanate extends the antibacterial spectrum of amoxycillin by making it active against resistant beta-lactamase producing bacteria.
-
Dosage
Shake the vial to suspend the active material. Inject subcutaneously or intramuscularly, then massage the injection site. Dose at 8.75 mg combined active constituents/kg bodyweight, equivalent to 1mL of suspension per 20kg bodyweight. Treatment should be administered once daily for 3 to 5 days.
Prefer to speak directly to a member of our team?
Norbrook Laboratories Australia Pty Ltd.
We are open Mon - Fri 9:00am - 5:00pm
Please note: Product information presented on this website is intended only as a brief summary of Norbrook products for your convenience. Not all products or indications are licensed in every country and may be subject to further local variations. For specific product information you should always consult a healthcare professional from your region or visit the local government agency website for the most up to date information. Please see our terms and conditions for further information.